|
|
|
|
|
|
|
Viking Therapeutics Inc. (VKTX)
|
|
13.83 -0.61 (-4.22%)
|
10-19 16:00
|
|
Open:
|
14.52
|
Pre. Close:
|
14.44
|
|
High:
|
14.65
|
Low:
|
13.75
|
|
Volume:
|
2,440,150
|
Market Cap:
|
970M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.666 - 14.786
|
14.786 - 14.866
|
|
Low:
|
13.512 - 13.638
|
13.638 - 13.723
|
|
Close:
|
13.664 - 13.86
|
13.86 - 13.992
|
|
|
|
Technical analysis (as of: 2018-10-19 4:40:23 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 21.92 One year: 28.03
|
|
Support:
|
Support1: 10.31 Support2: 8.58
|
|
Resistance:
|
Resistance1:
18.77 Resistance2: 24.00
|
|
Pivot:
|
14.82
|
|
Moving Averages:
|
MA(5): 14.52 MA(20): 15.69
MA(100): 12.04  MA(250): 7.53
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): 0.30
|
|
%K %D:
|
%K(14,3): 21.33 %D(3): 25.38
|
|
RSI:
|
RSI(14): 44.71
|
|
52-Week:
|
High: 24
Low: 2.08 Change(%): 393.9
|
|
Average Vol(K):
|
3-Month: 408268
10-Days 341131
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.VKTX has closed above bottom band by 17.6%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to VKTX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-10-19T12:04:35-04:00
Biotech Stocks Bloodied But Can Now Drive M&A
2018-10-19T10:49:10-04:00
Viking Therapeutics: A Valuation
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
